Get the Stockscreener App
1.2552
14.24%
-0.2248
Calidi Biotherapeutics Inc Stock (CLDI) Forecast
The Calidi Biotherapeutics Inc (CLDI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.239, representing a +237.72% increase from the current price of $1.2552. The highest analyst price target is $4.2207, and the lowest is $4.2573.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLDI Price Target
Average 4.0283
(+220.93% Upside)
Is Calidi Biotherapeutics Inc (CLDI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.95 | Neutral |
| STOCH(9,6) | 81.19 | Sell |
| STOCHRSI(14) | 78.34 | Neutral |
| MACD(12,26) | -0.0118 | Buy |
| ADX(14) | 32.27 | Buy |
| William %R | -22.84 | Neutral |
| CCI(14) | 97.00 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9845
Buy
|
1.1139
Buy
|
| MA20 |
0.9186
Buy
|
1.0698
Buy
|
| MA50 |
1.3726
Sell
|
1.2322
Buy
|
| MA100 |
1.3753
Sell
|
1.5333
Sell
|
| MA200 |
1.5887
Sell
|
3.6894
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CLDI could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CLDI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 56.95 indicates that CLDI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.19 indicates that CLDI is oversold. This means that CLDI price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.34 indicates that CLDI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.27 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 97 indicates that CLDI is still overbought but not to an extreme extent.
Long-term CLDI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Calidi Biotherapeutics Inc financial reports and earnings history, Calidi Biotherapeutics Inc (CLDI) stock could reach $7.7302 by 2030, $42.91 by 2040 and $104.99 by 2050. See the projected annual prices until 2050 of the Calidi Biotherapeutics Inc stock below:
- Calidi Biotherapeutics Inc (CLDI) is expected to reach an average price of $16.63 in 2035, with a high prediction of $22.22 and a low estimate of $16.69. This indicates an $1,225% rise from the last recorded price of $1.2552.
- Calidi Biotherapeutics Inc (CLDI) stock is projected to chart a bullish course in 2040, with an average price target of $37.27, representing an $2,869% surge from its current level. The forecast ranges from a conservative $37.35 to a sky-high $42.91.
- Our analysts predict Calidi Biotherapeutics Inc (CLDI) to jump 4,898% by 2045, soaring from $62.89 to an average price of $62.74, potentially reaching $70.21. While $62.89 is the low estimate, the potential upside is significant.
- Calidi Biotherapeutics Inc (CLDI) stock is expected to climb by 2050, reaching an average of $94.90, a $7,461% jump from its current level. However, a wide range of estimates exists, with high and low targets of $104.99 and $95.15, respectively, highlighting the market's uncertainty.
Calidi Biotherapeutics Inc Stock (CLDI) Year by Year Forecast
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2025
Calidi Biotherapeutics Inc Stock (CLDI) is expected to reach an average price of $3.8881 in 2025, with a high prediction of $7.671 and a low estimate of $0.1052. This indicates an +209.76% rise from the last recorded price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $4.1674 | $4.2573 | $4.2207 | +232.01% |
| April, 2025 | $3.0708 | $3.3008 | $3.7807 | +144.64% |
| May, 2025 | $2.9675 | $3.0074 | $2.9308 | +136.41% |
| June, 2025 | $2.8542 | $2.8542 | $2.7575 | +127.39% |
| July, 2025 | $2.0905 | $2.0905 | $2.6608 | +66.55% |
| August, 2025 | $1.3342 | $1.3542 | $1.8342 | +6.29% |
| September, 2025 | $0.9789 | $0.9542 | $1.0989 | -22.01% |
| October, 2025 | $7.956 | $0.3856 | $7.481 | +533.84% |
| November, 2025 | $7.7711 | $7.7711 | $7.671 | +519.11% |
| December, 2025 | $6.8711 | $6.9711 | $7.4011 | +447.41% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2026
The predicted value for Calidi Biotherapeutics Inc (CLDI) in 2026 is set at an average of $6.0004. Estimates vary from a peak of $11.33 to a trough of $0.6661, indicating an +378.04% surge from the present price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5112 | $5.5112 | $6.0911 | +339.07% |
| February, 2026 | $5.0612 | $5.0812 | $5.2412 | +303.22% |
| March, 2026 | $4.3913 | $4.4712 | $4.6812 | +249.85% |
| April, 2026 | $3.114 | $3.1413 | $4.0785 | +148.09% |
| May, 2026 | $2.0163 | $2.0239 | $2.6513 | +60.64% |
| June, 2026 | $1.2607 | $1.2779 | $1.6613 | +0.44% |
| July, 2026 | $11.73 | $0.6661 | $11.33 | +834.89% |
| August, 2026 | $10.93 | $11.14 | $11.11 | +770.63% |
| September, 2026 | $9.0748 | $9.4348 | $10.58 | +622.98% |
| October, 2026 | $7.9582 | $8.0149 | $8.5582 | +534.02% |
| November, 2026 | $6.9616 | $6.9716 | $7.5516 | +454.62% |
| December, 2026 | $5.6013 | $5.6663 | $6.605 | +346.25% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Calidi Biotherapeutics Inc (CLDI) is $9.9193, with a high forecast of $18.89 and a low forecast of $0.9466. This indicates an +690.26% increase from the last price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.9707 | $4.0392 | $4.3284 | +216.34% |
| February, 2027 | $2.659 | $2.6601 | $3.5151 | +111.84% |
| March, 2027 | $1.3925 | $0.9466 | $1.8385 | +10.94% |
| April, 2027 | $14.70 | $14.94 | $15.03 | +1,071% |
| May, 2027 | $13.95 | $14.40 | $14.20 | +1,012% |
| June, 2027 | $11.30 | $11.55 | $13.35 | +799.87% |
| July, 2027 | $10.04 | $10.18 | $10.37 | +700.03% |
| August, 2027 | $8.6487 | $8.7738 | $9.5386 | +589.03% |
| September, 2027 | $6.1721 | $6.7021 | $8.1354 | +391.72% |
| October, 2027 | $4.6319 | $4.6933 | $5.5755 | +269.01% |
| November, 2027 | $2.6408 | $2.9556 | $4.0884 | +110.39% |
| December, 2027 | $19.09 | $1.227 | $18.89 | +1,421% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2028
In 2028, Calidi Biotherapeutics Inc (CLDI) is projected to reach an average price of $12.13, with a high projection of $22.75 and a low estimate of $1.5075. This indicates an +866.24% rise from the last price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.21 | $18.42 | $18.76 | +1,351% |
| February, 2028 | $16.50 | $16.59 | $17.31 | +1,215% |
| March, 2028 | $13.47 | $13.70 | $15.38 | +973.32% |
| April, 2028 | $11.82 | $11.97 | $12.62 | +841.87% |
| May, 2028 | $9.5826 | $9.6625 | $11.09 | +663.43% |
| June, 2028 | $7.4656 | $7.4656 | $8.9798 | +494.77% |
| July, 2028 | $5.1626 | $5.1826 | $6.8226 | +311.30% |
| August, 2028 | $2.6821 | $2.6993 | $4.5407 | +113.68% |
| September, 2028 | $23.00 | $1.5075 | $22.75 | +1,732% |
| October, 2028 | $21.27 | $21.27 | $22.33 | +1,594% |
| November, 2028 | $18.43 | $18.53 | $20.31 | +1,368% |
| December, 2028 | $15.53 | $15.53 | $17.27 | +1,137% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2029
The 2029 price forecast for Calidi Biotherapeutics Inc Stock (CLDI) is $14.20 on average, with a high prediction of $26.61 and a low estimate of $1.788. This represents an +1,031% increase from the previous price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.02 | $13.03 | $14.81 | +937.51% |
| February, 2029 | $10.85 | $10.90 | $12.38 | +764.59% |
| March, 2029 | $8.1024 | $8.1297 | $9.9196 | +545.50% |
| April, 2029 | $5.4581 | $5.4657 | $7.253 | +334.84% |
| May, 2029 | $2.4449 | $2.48 | $4.7165 | +94.78% |
| June, 2029 | $26.39 | $1.788 | $26.61 | +2,002% |
| July, 2029 | $24.04 | $24.27 | $25.38 | +1,815% |
| August, 2029 | $20.25 | $20.61 | $23.30 | +1,513% |
| September, 2029 | $17.59 | $17.67 | $19.35 | +1,301% |
| October, 2029 | $14.42 | $14.55 | $16.79 | +1,049% |
| November, 2029 | $11.75 | $11.81 | $13.62 | +836.08% |
| December, 2029 | $8.5725 | $8.641 | $10.08 | +582.96% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2030
Calidi Biotherapeutics Inc Stock (CLDI) is expected to reach an average price of $18.19 in 2030, with a high forecast of $34.32 and a low forecast of $2.0684. This signifies an +1,350% surge from the last price of $1.2552.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6421 | $4.9569 | $7.7302 | +269.83% |
| February, 2030 | $2.946 | $2.0684 | $3.8236 | +134.71% |
| March, 2030 | $28.96 | $29.20 | $30.46 | +2,207% |
| April, 2030 | $26.67 | $27.12 | $28.08 | +2,025% |
| May, 2030 | $22.08 | $22.33 | $25.68 | +1,659% |
| June, 2030 | $19.28 | $19.42 | $20.77 | +1,436% |
| July, 2030 | $15.64 | $15.64 | $18.39 | +1,146% |
| August, 2030 | $11.93 | $12.46 | $14.77 | +850.75% |
| September, 2030 | $8.8469 | $8.9083 | $10.56 | +604.82% |
| October, 2030 | $4.9721 | $4.9791 | $7.9169 | +296.12% |
| November, 2030 | $34.52 | $2.3489 | $34.32 | +2,650% |
| December, 2030 | $32.09 | $32.30 | $33.80 | +2,457% |
0.53%
Cap:
|
Volume (24h):